Evidence map›Paper›PMID 25395463›Full record

ArticleNeuro-oncology2015

White matter compromise predicts poor intellectual outcome in survivors of pediatric low-grade glioma.

Fang Liu, Nadia Scantlebury, Uri Tabori, Eric Bouffet, Suzanne Laughlin, Douglas Strother, Dina McConnell, Juliette Hukin, Chris Fryer, Marie-Eve Brière and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuro-oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Long-term quality of survival after pediatric low-grade glioma.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2024
    Review
  3. Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  4. Article
  5. The anatomy of neuroepithelial tumours.Brain : a journal of neurology · 2023
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Brain Imaging in Pediatric Cancer Survivors: Correlates of Cognitive Impairment.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021
    Review
  13. Cognitive Risk in Survivors of Pediatric Brain Tumors.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021
    Review
  14. Review
  15. Article
  16. Article
  17. Changes in White Matter Microstructure Impact Cognition by Disrupting the Ability of Neural Assemblies to Synchronize.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Fang LiuNeurosciences & Mental Health, The Hospital for Sick Children, Toronto, Ontario, Canada (F.L., N.S., F.W., D.J.M.); Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada (U.T., E.B.); Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada (U.T., E.B.); Diagnostic Imaging, The Hospital for Sick Children, Toronto, Ontario, Canada (S.L.); Medical Imaging, University of Toronto, Toronto, Ontario, Canada (S.L.); Departments of Oncology and Pediatrics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (D.S.); Independent practice, Montréal area, Québec, Canada (M.-E.B.); Department of Psychology, Division of Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (D.M.); Divisions of Neurology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (J.H.); Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada (J.H., C.F.); Division of Hematology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (C.F.); Division of Ambulatory Care/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada (I.M.-P., D.K.); Department of Pediatrics, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada (D.K.); Department of Psychology, The Hospital for Sick Children, Toronto, Ontario, Canada (D.J.M.); Department of Psychology, University of Toronto, Toronto, Ontario, Canada (D.J.M.).
Nadia ScantleburyNeurosciences & Mental Health, The Hospital for Sick Children, Toronto, Ontario, Canada (F.L., N.S., F.W., D.J.M.); Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada (U.T., E.B.); Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada (U.T., E.B.); Diagnostic Imaging, The Hospital for Sick Children, Toronto, Ontario, Canada (S.L.); Medical Imaging, University of Toronto, Toronto, Ontario, Canada (S.L.); Departments of Oncology and Pediatrics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (D.S.); Independent practice, Montréal area, Québec, Canada (M.-E.B.); Department of Psychology, Division of Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (D.M.); Divisions of Neurology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (J.H.); Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada (J.H., C.F.); Division of Hematology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (C.F.); Division of Ambulatory Care/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada (I.M.-P., D.K.); Department of Pediatrics, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada (D.K.); Department of Psychology, The Hospital for Sick Children, Toronto, Ontario, Canada (D.J.M.); Department of Psychology, University of Toronto, Toronto, Ontario, Canada (D.J.M.).
Uri TaboriNeurosciences & Mental Health, The Hospital for Sick Children, Toronto, Ontario, Canada (F.L., N.S., F.W., D.J.M.); Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada (U.T., E.B.); Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada (U.T., E.B.); Diagnostic Imaging, The Hospital for Sick Children, Toronto, Ontario, Canada (S.L.); Medical Imaging, University of Toronto, Toronto, Ontario, Canada (S.L.); Departments of Oncology and Pediatrics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (D.S.); Independent practice, Montréal area, Québec, Canada (M.-E.B.); Department of Psychology, Division of Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (D.M.); Divisions of Neurology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (J.H.); Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada (J.H., C.F.); Division of Hematology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (C.F.); Division of Ambulatory Care/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada (I.M.-P., D.K.); Department of Pediatrics, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada (D.K.); Department of Psychology, The Hospital for Sick Children, Toronto, Ontario, Canada (D.J.M.); Department of Psychology, University of Toronto, Toronto, Ontario, Canada (D.J.M.).
Eric BouffetNeurosciences & Mental Health, The Hospital for Sick Children, Toronto, Ontario, Canada (F.L., N.S., F.W., D.J.M.); Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada (U.T., E.B.); Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada (U.T., E.B.); Diagnostic Imaging, The Hospital for Sick Children, Toronto, Ontario, Canada (S.L.); Medical Imaging, University of Toronto, Toronto, Ontario, Canada (S.L.); Departments of Oncology and Pediatrics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (D.S.); Independent practice, Montréal area, Québec, Canada (M.-E.B.); Department of Psychology, Division of Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (D.M.); Divisions of Neurology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (J.H.); Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada (J.H., C.F.); Division of Hematology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (C.F.); Division of Ambulatory Care/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada (I.M.-P., D.K.); Department of Pediatrics, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada (D.K.); Department of Psychology, The Hospital for Sick Children, Toronto, Ontario, Canada (D.J.M.); Department of Psychology, University of Toronto, Toronto, Ontario, Canada (D.J.M.).
Suzanne LaughlinNeurosciences & Mental Health, The Hospital for Sick Children, Toronto, Ontario, Canada (F.L., N.S., F.W., D.J.M.); Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada (U.T., E.B.); Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada (U.T., E.B.); Diagnostic Imaging, The Hospital for Sick Children, Toronto, Ontario, Canada (S.L.); Medical Imaging, University of Toronto, Toronto, Ontario, Canada (S.L.); Departments of Oncology and Pediatrics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (D.S.); Independent practice, Montréal area, Québec, Canada (M.-E.B.); Department of Psychology, Division of Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (D.M.); Divisions of Neurology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (J.H.); Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada (J.H., C.F.); Division of Hematology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (C.F.); Division of Ambulatory Care/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada (I.M.-P., D.K.); Department of Pediatrics, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada (D.K.); Department of Psychology, The Hospital for Sick Children, Toronto, Ontario, Canada (D.J.M.); Department of Psychology, University of Toronto, Toronto, Ontario, Canada (D.J.M.).
Douglas StrotherNeurosciences & Mental Health, The Hospital for Sick Children, Toronto, Ontario, Canada (F.L., N.S., F.W., D.J.M.); Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada (U.T., E.B.); Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada (U.T., E.B.); Diagnostic Imaging, The Hospital for Sick Children, Toronto, Ontario, Canada (S.L.); Medical Imaging, University of Toronto, Toronto, Ontario, Canada (S.L.); Departments of Oncology and Pediatrics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (D.S.); Independent practice, Montréal area, Québec, Canada (M.-E.B.); Department of Psychology, Division of Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (D.M.); Divisions of Neurology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (J.H.); Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada (J.H., C.F.); Division of Hematology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (C.F.); Division of Ambulatory Care/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada (I.M.-P., D.K.); Department of Pediatrics, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada (D.K.); Department of Psychology, The Hospital for Sick Children, Toronto, Ontario, Canada (D.J.M.); Department of Psychology, University of Toronto, Toronto, Ontario, Canada (D.J.M.).
Dina McConnellNeurosciences & Mental Health, The Hospital for Sick Children, Toronto, Ontario, Canada (F.L., N.S., F.W., D.J.M.); Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada (U.T., E.B.); Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada (U.T., E.B.); Diagnostic Imaging, The Hospital for Sick Children, Toronto, Ontario, Canada (S.L.); Medical Imaging, University of Toronto, Toronto, Ontario, Canada (S.L.); Departments of Oncology and Pediatrics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (D.S.); Independent practice, Montréal area, Québec, Canada (M.-E.B.); Department of Psychology, Division of Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (D.M.); Divisions of Neurology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (J.H.); Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada (J.H., C.F.); Division of Hematology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (C.F.); Division of Ambulatory Care/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada (I.M.-P., D.K.); Department of Pediatrics, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada (D.K.); Department of Psychology, The Hospital for Sick Children, Toronto, Ontario, Canada (D.J.M.); Department of Psychology, University of Toronto, Toronto, Ontario, Canada (D.J.M.).
Juliette HukinNeurosciences & Mental Health, The Hospital for Sick Children, Toronto, Ontario, Canada (F.L., N.S., F.W., D.J.M.); Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada (U.T., E.B.); Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada (U.T., E.B.); Diagnostic Imaging, The Hospital for Sick Children, Toronto, Ontario, Canada (S.L.); Medical Imaging, University of Toronto, Toronto, Ontario, Canada (S.L.); Departments of Oncology and Pediatrics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (D.S.); Independent practice, Montréal area, Québec, Canada (M.-E.B.); Department of Psychology, Division of Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (D.M.); Divisions of Neurology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (J.H.); Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada (J.H., C.F.); Division of Hematology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (C.F.); Division of Ambulatory Care/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada (I.M.-P., D.K.); Department of Pediatrics, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada (D.K.); Department of Psychology, The Hospital for Sick Children, Toronto, Ontario, Canada (D.J.M.); Department of Psychology, University of Toronto, Toronto, Ontario, Canada (D.J.M.).
Chris FryerNeurosciences & Mental Health, The Hospital for Sick Children, Toronto, Ontario, Canada (F.L., N.S., F.W., D.J.M.); Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada (U.T., E.B.); Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada (U.T., E.B.); Diagnostic Imaging, The Hospital for Sick Children, Toronto, Ontario, Canada (S.L.); Medical Imaging, University of Toronto, Toronto, Ontario, Canada (S.L.); Departments of Oncology and Pediatrics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (D.S.); Independent practice, Montréal area, Québec, Canada (M.-E.B.); Department of Psychology, Division of Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (D.M.); Divisions of Neurology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (J.H.); Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada (J.H., C.F.); Division of Hematology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (C.F.); Division of Ambulatory Care/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada (I.M.-P., D.K.); Department of Pediatrics, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada (D.K.); Department of Psychology, The Hospital for Sick Children, Toronto, Ontario, Canada (D.J.M.); Department of Psychology, University of Toronto, Toronto, Ontario, Canada (D.J.M.).
Marie-Eve BrièreNeurosciences & Mental Health, The Hospital for Sick Children, Toronto, Ontario, Canada (F.L., N.S., F.W., D.J.M.); Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada (U.T., E.B.); Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada (U.T., E.B.); Diagnostic Imaging, The Hospital for Sick Children, Toronto, Ontario, Canada (S.L.); Medical Imaging, University of Toronto, Toronto, Ontario, Canada (S.L.); Departments of Oncology and Pediatrics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (D.S.); Independent practice, Montréal area, Québec, Canada (M.-E.B.); Department of Psychology, Division of Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (D.M.); Divisions of Neurology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (J.H.); Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada (J.H., C.F.); Division of Hematology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (C.F.); Division of Ambulatory Care/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada (I.M.-P., D.K.); Department of Pediatrics, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada (D.K.); Department of Psychology, The Hospital for Sick Children, Toronto, Ontario, Canada (D.J.M.); Department of Psychology, University of Toronto, Toronto, Ontario, Canada (D.J.M.).
Isabelle Montour-ProulxNeurosciences & Mental Health, The Hospital for Sick Children, Toronto, Ontario, Canada (F.L., N.S., F.W., D.J.M.); Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada (U.T., E.B.); Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada (U.T., E.B.); Diagnostic Imaging, The Hospital for Sick Children, Toronto, Ontario, Canada (S.L.); Medical Imaging, University of Toronto, Toronto, Ontario, Canada (S.L.); Departments of Oncology and Pediatrics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (D.S.); Independent practice, Montréal area, Québec, Canada (M.-E.B.); Department of Psychology, Division of Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (D.M.); Divisions of Neurology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (J.H.); Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada (J.H., C.F.); Division of Hematology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (C.F.); Division of Ambulatory Care/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada (I.M.-P., D.K.); Department of Pediatrics, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada (D.K.); Department of Psychology, The Hospital for Sick Children, Toronto, Ontario, Canada (D.J.M.); Department of Psychology, University of Toronto, Toronto, Ontario, Canada (D.J.M.).
Daniel KeeneNeurosciences & Mental Health, The Hospital for Sick Children, Toronto, Ontario, Canada (F.L., N.S., F.W., D.J.M.); Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada (U.T., E.B.); Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada (U.T., E.B.); Diagnostic Imaging, The Hospital for Sick Children, Toronto, Ontario, Canada (S.L.); Medical Imaging, University of Toronto, Toronto, Ontario, Canada (S.L.); Departments of Oncology and Pediatrics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (D.S.); Independent practice, Montréal area, Québec, Canada (M.-E.B.); Department of Psychology, Division of Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (D.M.); Divisions of Neurology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (J.H.); Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada (J.H., C.F.); Division of Hematology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (C.F.); Division of Ambulatory Care/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada (I.M.-P., D.K.); Department of Pediatrics, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada (D.K.); Department of Psychology, The Hospital for Sick Children, Toronto, Ontario, Canada (D.J.M.); Department of Psychology, University of Toronto, Toronto, Ontario, Canada (D.J.M.).
Frank WangNeurosciences & Mental Health, The Hospital for Sick Children, Toronto, Ontario, Canada (F.L., N.S., F.W., D.J.M.); Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada (U.T., E.B.); Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada (U.T., E.B.); Diagnostic Imaging, The Hospital for Sick Children, Toronto, Ontario, Canada (S.L.); Medical Imaging, University of Toronto, Toronto, Ontario, Canada (S.L.); Departments of Oncology and Pediatrics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (D.S.); Independent practice, Montréal area, Québec, Canada (M.-E.B.); Department of Psychology, Division of Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (D.M.); Divisions of Neurology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (J.H.); Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada (J.H., C.F.); Division of Hematology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (C.F.); Division of Ambulatory Care/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada (I.M.-P., D.K.); Department of Pediatrics, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada (D.K.); Department of Psychology, The Hospital for Sick Children, Toronto, Ontario, Canada (D.J.M.); Department of Psychology, University of Toronto, Toronto, Ontario, Canada (D.J.M.).
Donald J MabbottNeurosciences & Mental Health, The Hospital for Sick Children, Toronto, Ontario, Canada (F.L., N.S., F.W., D.J.M.); Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada (U.T., E.B.); Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada (U.T., E.B.); Diagnostic Imaging, The Hospital for Sick Children, Toronto, Ontario, Canada (S.L.); Medical Imaging, University of Toronto, Toronto, Ontario, Canada (S.L.); Departments of Oncology and Pediatrics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada (D.S.); Independent practice, Montréal area, Québec, Canada (M.-E.B.); Department of Psychology, Division of Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (D.M.); Divisions of Neurology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (J.H.); Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada (J.H., C.F.); Division of Hematology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada (C.F.); Division of Ambulatory Care/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada (I.M.-P., D.K.); Department of Pediatrics, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada (D.K.); Department of Psychology, The Hospital for Sick Children, Toronto, Ontario, Canada (D.J.M.); Department of Psychology, University of Toronto, Toronto, Ontario, Canada (D.J.M.).
Hospital for Sick Children · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhile the impact of cranial radiation on white matter following treatment for pediatric brain tumor has been the focus of many recent studies, the effect of treatment in the absence of radiation has received little attention. The relations between white matter and cognitive outcome have not been explored in patients who have undergone radiation-free treatment. As most patients treated without cranial radiation survive long after their diagnosis, it is critical to identify factors that may impact structural and neurocognitive outcomes.

methodsUsing diffusion tensor imaging, we examined white matter structure in 32 patients with pediatric low-grade glioma (PLGG) (19 with subtentorial location and 13 with supratentorial location) and 32 healthy participants. Indices of intellectual functioning were also evaluated. Radiation was not used to treat this cohort, aged 8-19 years.

resultsWe detected evidence of deficits in IQ and compromised supra- and subtentorial white matter in patients relative to healthy children (P < .05). Compromise of supratentorial white matter mediated the impact of treatment for PLGG on IQ. Greater white matter compromise was observed in patients who presented without multiple symptoms, were treated with biopsy/no surgery, had positive neurofibromatosis 1 status, were younger age at diagnosis, and whose parents had lower levels of education (P < .05).

conclusionsOur findings provide evidence of increased risk of intellectual and white matter compromise in patients treated for PLGG without radiation. We identify a neural origin of cognitive deficit useful for predicting outcome and mitigating long-term adverse effects in pediatric brain tumor patients treated without cranial radiation.

Indexed as

IntelligenceAdolescentAdultBrainChildDiffusion Tensor ImagingFemaleGliomaHumansIntelligence TestsMaleNeuropsychological TestsPrognosisWhite MatterYoung AdultIQlow-grade gliomasubtentorial tumorssupratentorial tumorswhite matter

Identifiers

PMID25395463
PMCPMC4483078
OpenAlexW2322670822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.